These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8357123)

  • 1. Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1.
    Ridker PM; O'Donnell C; Marder VJ; Hennekens CH
    Ann Intern Med; 1993 Sep; 119(6):530-2. PubMed ID: 8357123
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic therapy: pre- and post-GISSI-2, ISIS-3, and GUSTO-1.
    Hennekens CH
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I15-7. PubMed ID: 8156657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unresolved issues after the available comparative trials of thrombolytic agents in acute myocardial infarction.
    Collen D
    Z Kardiol; 1993; 82 Suppl 2():119-23. PubMed ID: 8328188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological thrombolysis in acute myocardial infarction. Lessons learned from ISIS-2 and GUSTO-1. I].
    Jerjes-Sánchez C; Garza-Ruiz A; Gutiérrez-Fajardo P
    Arch Inst Cardiol Mex; 1999; 69(5):478-87. PubMed ID: 10640212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolytic therapy of myocardial infarct. Status after GISSI-2 and ISIS-3].
    Gulba DC; Claus G
    Internist (Berl); 1992 Apr; 33(4):206-15. PubMed ID: 1612844
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Van de Werf F; Califf RM; Armstrong PW; Bates ER; Ross AM; Kleinman NS; Topol EJ
    Eur Heart J; 1995 Aug; 16(8):1024-6. PubMed ID: 8665962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].
    Slama M; Cohen-Solal A; Spriet A
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic treatment in acute myocardial infarction].
    Røde R
    Tidsskr Nor Laegeforen; 1989 Feb; 109(4):428-9. PubMed ID: 2645687
    [No Abstract]   [Full Text] [Related]  

  • 10. Reperfusion therapy in acute myocardial infarction: present status and controversy.
    Mueller HS
    Clin Cardiol; 1990 Apr; 13(4):239-46. PubMed ID: 2190722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do results from major clinical trials indicate a change in management in the acute phase of myocardial infarction?
    Hjalmarson A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S2-8; discussion S9. PubMed ID: 2481164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the GUSTO trial for thrombolytic therapy.
    Van de Werf F
    Drugs; 1996 Sep; 52(3):307-12. PubMed ID: 8875125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of thrombolytic therapy to patients with acute myocardial infarction.
    Quinn T; Thompson DR
    Accid Emerg Nurs; 1995 Oct; 3(4):208-14. PubMed ID: 8520942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy: a review of its use in acute myocardial infarction.
    Bizjak ED; Mauro VF
    Ann Pharmacother; 1998; 32(7-8):769-84. PubMed ID: 9681094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous thrombolytic therapy in myocardial infarction (review)].
    Staroverov II
    Ter Arkh; 2003; 75(10):80-3. PubMed ID: 14669614
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
    Ferreira D
    Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
    [No Abstract]   [Full Text] [Related]  

  • 18. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point.
    Braunwald E; Cannon CP; McCabe CH
    Circulation; 1992 Aug; 86(2):683-7. PubMed ID: 1638732
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspectives gained from large-scale thrombolytic comparative trials.
    Armstrong PW
    Eur Heart J; 1996 Sep; 17 Suppl E():9-13. PubMed ID: 11824006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.